Skip to content
Melsmon · Japan

Melsmon Placenta (Human) 2ml x 50 vials, concentrated placenta formula, anti-aging (Korea) Imported

Japanese human placenta solution, 50 x 2 ml ampoules

฿23,100
Size
Price฿23,100
1
Price฿23,100
1
Ask on LINE
Genuine imported stock, lot-checked before shipping
EMS delivery in Thailand 60 THB, dispatched once payment is confirmed
Product warranty

Record an unboxing video every time, from before you open the parcel until it is unpacked, in one uncut take. Without the video, no claim can be accepted.

You can claim

  • A product that arrives broken, damaged or missing
  • The wrong product, still unopened
  • An opened product, only when the item inside is cracked or broken

No claim

  • An opened product in normal condition
  • More than 7 days after delivery without an unboxing video

Benefits of Melsmon Placenta (Human) 2ml x 50 vials, concentrated placenta formula, anti-aging (Korea)

  • Anti-aging
  • Concentrated placenta formula

Results vary from person to person

What is Melsmon Placenta (Human) 2ml x 50 vials, concentrated placenta formula, anti-aging (Korea)?

Melsmon Placenta (Human) is an injectable solution of human placenta hydrolysate made by Melsmon Pharmaceutical of Japan, in 2 mL ampoules, 50 ampoules to the carton.

In short

  • Each ampoule contains 100 mg of the water-soluble hydrolysate of human placental villous tissue, with benzyl alcohol as the excipient. The prescribing information names no single substance as the active ingredient, because many trace components are present; sixteen amino acids have been quantified.
  • Japan's prescribing information gives the route as subcutaneous injection only, on a doctor's prescription. Buyers should not inject it themselves.
  • The starting material is human placenta, unlike products made from animal placenta and unlike creams or supplements that use the placenta name.

Indications in Japan's prescribing information

In Japan, Melsmon is a prescription-only medicine and is classed as a specified biological product (特定生物由来製品). The indications in the prescribing information are menopausal disorders and insufficient lactation.

This is label information for Japan. Who should receive the product, how much and for how long are decisions a doctor makes for each patient. The most recent prescribing information used here is the December 2023 revision.

Placenta screening and manufacture

According to the prescribing information, the maker uses human placentas collected in Japan. Donors are interviewed, blood is tested for viral and bacterial infection, and nucleic acid amplification tests (NAT) are run for HBV, HCV and HIV-1. Only placentas that pass are used.

A 2025 review in Frontiers in Pharmacology outlines the process: the umbilical cord is removed, blood is washed out of the villous portion, and the tissue is extracted and purified by hydrochloric acid hydrolysis. The pH is adjusted to 7.0, benzyl alcohol is added, and the filled ampoules are sterilised with high-pressure steam.

Cautions and side effects listed on the label

The product must not be given to anyone with a history of hypersensitivity to it or to other drugs. The prescribing information lists chills, nausea, fever, redness and rash, and pain or redness at the injection site. Shock is listed as a serious side effect.

Tell the doctor about drug allergies, medical conditions, pregnancy or breastfeeding before an injection.

Frequently asked questions

What is placenta?

In Melsmon, placenta means human placenta digested with hydrochloric acid, leaving the water-soluble part that is made into an injectable solution.

Is there an infection risk with a medicine made from human placenta?

The prescribing information states that screening and inactivation cannot remove the risk of transmitting infection completely. No transmission of variant Creutzfeldt-Jakob disease (vCJD) from this product has been reported, but a theoretical risk cannot be ruled out.

Are all human placenta extracts the same?

No. A 2025 review in Frontiers in Pharmacology reports that human placental extracts from different makers are produced by different methods, so their compositions differ.

Why must the clinic record the lot number of Melsmon?

Melsmon is made from human placenta, which Japan classes as a specified biological product. The prescribing information therefore requires the clinic to record the drug name, lot number, date of use and patient details, and keep the record for at least 20 years so the product can be traced.

How much is Melsmon Placenta?

The price depends on the model and the quantity.

References

  1. Melsmon (prescribing information, Japan). Pharmaceuticals and Medical Devices Agency, Japan (PMDA) (2023) pmda.go.jp/PmdaSearch/iyakuDetail/780056_3259600A1020_1_06(opens in a new tab)
  2. Melsmon Pharmaceutical Co., Ltd. (company and product information). Melsmon Pharmaceutical Co., Ltd. melsmon.co.jp/(opens in a new tab)
  3. Biological effects of human placental extracts: variations in manufacturing methods and compositions. Frontiers in Pharmacology (2025) frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1707890/full(opens in a new tab)

This information is for general knowledge and does not replace a doctor's advice. Every procedure should be performed by a licensed doctor in a medical facility.

You may also like

Shop all